View in EDS HTML Full Text PDF Full Text

3CLpro of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study.

Saved in:
Bibliographic Details
Title: 3CLpro of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study.
Authors: Kayumov, Muzaffar1 (AUTHOR) mqayumov0808@gmail.com, Razzokov, Jamoliddin2,3,4 (AUTHOR), Makhkamov, Mukhriddin5 (AUTHOR), Radjabov, Murodjon6 (AUTHOR), Mukhamedov, Nurkhodja1,6 (AUTHOR), Khakimov, Makhmudjon1 (AUTHOR), Asrorov, Akmal M.1,7 (AUTHOR), Khasanov, Okhunjon8 (AUTHOR), Yashinov, Ansor1,9 (AUTHOR), Tashmukhamedov, Mugrajitdin1,10 (AUTHOR), Wali, Ahmidin11 (AUTHOR), Yili, Abulimiti11 (AUTHOR), Mirzaakhmedov, Sharafitdin1 (AUTHOR)
Source: Journal of Computer-Aided Molecular Design. 7/5/2025, Vol. 39 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0920654X
DOI:10.1007/s10822-025-00623-2